We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Imaging Study May Lead to More-Effective Smoking Cessation

By HospiMedica staff writers
Posted on 21 Aug 2006
Results of a new imaging study demonstrated that the nicotine received in just a few drags of a cigarette can exert a force powerful enough to drive an individual to continue smoking. More...


Researchers supported in part by the U.S. National Institute on Drug Abuse (NIDA; Rockville, MD, USA), U.S. National Institutes of Health (NIH), discovered that the amount of nicotine contained in just one puff of a cigarette can occupy about 30% of the brain's most common type of nicotine receptors, while three puffs of a cigarette can occupy about 70% of these receptors. When nearly all of the receptors are occupied (as a result of smoking at least two and one-half cigarettes), the smoker becomes satisfied, for a time. Soon, however, this level of satiation wears off, forcing the smoker to continue smoking throughout the day to satisfy cigarette cravings.

The study was published in the August 2006 issue of the journal Archives of General Psychiatry. The scientists, led by Dr. Arthur Brody of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA; USA), utilized positron emission tomography (PET) to scan the brains of 11 smokers and assess nicotine distribution. During the scanning sessions, the participants smoked one of five amounts--none, one puff, three puffs, one full cigarette, or until their craving was satisfied (two and one-half to three cigarettes). Craving was measured with the Urge to Smoke scale, which evaluates responses to 10 craving-related questions. The scientists also performed magnetic resonance imaging (MRI) studies to help localize regions on the PET scans.

The investigators discovered that the highest levels of nicotine binding occurred in the thalamus (an area of the brain that acts as a conduit for all sensory data that reaches the brain's cerebral cortex, and which contains the highest concentration of these nicotine receptors), the brainstem (which controls various automatic functions, such as respiration, heart rate, and arousal), and the cerebellum (the area of the brain responsible for the coordination of movement and balance). Findings of another recently published NIDA-supported study suggest that a portion of the cerebellum called the vermis may be a major factor in modulating the brain's dopamine and reward systems, and may be more involved in drug abuse and addiction than previously thought.



Related Links:
National Institute on Drug Abuse
University of California, Los Angeles

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.